Corticosteroids for pneumonia
79 results
1 - 79
Corticosteroids for pneumonia
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection - Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
Systemic corticosteroids reduce need for ICU or mechanical ventilation in patients with community-acquired pneumonia- Corticosteroids improve outcomes in patients with severe community-acquired pneumonia
- Inhaled corticosteroids increase pneumonia risk in stable COPD
- Inhaled steroids for COPD associated with increased risk of pneumonia
- Inhaled budesonide for COPD not associated with pneumonia
- Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Updated guidelines from the Society of Critical Care Medicine strongly recommend steroids for hospitalized adults with severe community-acquired pneumonia
- Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
- Risk of serious pneumonia in COPD patients using inhaled corticosteroids
- Inhaled corticosteroids in COPD
- A bundle of evidence-based strategies that includes steroids for the treatment of CAP does not improve outcomes
- Corticosteroids for treating sepsis in children and adults
- Dexamethasone reduces LOS in patients with community-acquired pneumonia
- Single course of antenatal steroids associated with small increased incidence of serious infection in infants
- Combined corticosteroid and long-acting beta-agonist in one inhaler for chronic obstructive pulmonary disease
- Corticosteroids for idiopathic pulmonary fibrosis
- Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
- HIV infection
- Intravenous hydrocortisone reduces all-cause mortality in severe community-acquired pneumonia (CAPE COD)
- The addition of steroids improves outcomes in children and adults with CAP
- Corticosteroids as adjunctive therapy in the treatment of influenza
- Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease
- Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
- Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
- COVID-19 research briefs: Wuhan patient outcomes, and new Infectious Disease Society of America treatment guidelines
- The American Thoracic Society guideline for managing patients with chronic obstructive pulmonary disease
- A single corticosteroid burst in children is associated with harms
- Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease: Cochrane systematic review
- Updated clinical guidelines for the diagnosis and treatment of CAP
- Subacute cough treatments: limited data, unclear benefits
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
- Dexamethasone may reduce sore throat symptoms in adults at 48 hours
- Cyclophosphomide reduces dyspnea in scleroderma lung disease
- Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
- Low-dose theophylline is minimally helpful, if at all, in preventing COPD exacerbations
- Low-dose oral = high-dose IV steroids for initial treatment of acute COPD exacerbation
- Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline
- Pharmacological agents for adults with acute respiratory distress syndrome
- Interventions for preventing critical illness polyneuropathy and critical illness myopathy
- Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
- Non‐invasive positive pressure ventilation for acute asthma in children
- Methotrexate for induction of remission in ulcerative colitis